1. Home
  2. TNXP vs SSKN Comparison

TNXP vs SSKN Comparison

Compare TNXP & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$18.81

Market Cap

231.3M

Sector

Health Care

ML Signal

HOLD

Logo Strata Skin Sciences Inc.

SSKN

Strata Skin Sciences Inc.

HOLD

Current Price

$1.33

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNXP
SSKN
Founded
2007
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.3M
8.9M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
TNXP
SSKN
Price
$18.81
$1.33
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$70.00
$6.00
AVG Volume (30 Days)
766.6K
80.8K
Earning Date
11-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,299,000.00
$30,980,000.00
Revenue This Year
$14.79
N/A
Revenue Next Year
$933.49
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$1.24
52 Week High
$130.00
$3.86

Technical Indicators

Market Signals
Indicator
TNXP
SSKN
Relative Strength Index (RSI) 53.01 41.53
Support Level $18.59 $1.37
Resistance Level $20.56 $1.52
Average True Range (ATR) 1.30 0.08
MACD 0.39 0.01
Stochastic Oscillator 73.13 16.67

Price Performance

Historical Comparison
TNXP
SSKN

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: